Replicating vectors for gene therapy of cancer: risks, limitations and prospects
- 31 December 1994
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (8) , 1165-1171
- https://doi.org/10.1016/0959-8049(94)90477-4
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?Immunology Today, 1994
- Regulating gene expression in gene therapyTrends in Biotechnology, 1993
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993
- Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer.The Journal of Experimental Medicine, 1992
- Establishment of tumor-specific immunotherapy model utilizing vaccinia virus-reactive helper T cell activityEuropean Journal of Immunology, 1988
- Cellular promoters incorporated into the adenovirus genomeJournal of Molecular Biology, 1987
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984
- Effects of Viruses on TumorsAnnual Review of Microbiology, 1954
- THE INFLUENCE OF COMPLICATING DISEASES UPON LEUKÆMIA.*The Lancet Healthy Longevity, 1904
- THE INFLUENCE OF COMPLICATING DISEASES UPON LEUKÆMIA.*The Lancet Healthy Longevity, 1904